Singapore, July 22 -- Australia-basedcontract development and manufacturing organisations Viral Vector Manufacturing Facility (VVMF) and Cell Therapies have co-signed a Memorandum of Understanding (MoU) to explore strategic collaboration opportunities aimed at strengthening the onshore development and manufacture of Advanced Therapy Medicinal Products (ATMPs).

Published by HT Digital Content Services with permission from BioSpectrum Asia....